[1]
Omar, R.M.K. et al. 2020. Pryazolylpyridine and Triazolylpyridine derivative of hydroxychloroquine as Potential Therapeutic against COVID-19: Theoretical Evaluation. Journal of Drug Delivery and Therapeutics. 10, 4-s (Aug. 2020), 181–186. DOI:https://doi.org/10.22270/jddt.v10i4-s.4298.